Criss, S. D., Mooradian, M. J., Watson, T. R., Gainor, J. F., Reynolds, K. L., & Kong, C. Y. (2019). Cost-effectiveness of Atezolizumab Combination Therapy for First-Line Treatment of Metastatic Nonsquamous Non–Small Cell Lung Cancer in the United States. JAMA Netw Open.

Criss, Steven D., Meghan J. Mooradian, Tina R. Watson, Justin F. Gainor, Kerry L. Reynolds, a Chung Yin Kong. "Cost-effectiveness of Atezolizumab Combination Therapy for First-Line Treatment of Metastatic Nonsquamous Non–Small Cell Lung Cancer in the United States." JAMA Netw Open 2019.

Criss, Steven D., et al. "Cost-effectiveness of Atezolizumab Combination Therapy for First-Line Treatment of Metastatic Nonsquamous Non–Small Cell Lung Cancer in the United States." JAMA Netw Open 2019.